Abstract
Objective: We report a case of neuroleptic malignant syndrome in a woman who assumed risperidone for schizoaffective disorders. Case Summary: A 45-year-old woman affected by schizoaffective disorders was admitted to Infectious Disease unit of Crotone Hospital because of a diagnosis of a fever of unknown origin. Clinical evaluation documented confusion and dysphoria, whereas chemical blood evaluation revealed acidosis and liver dysfunction. After few days she was transferred to the Operative Unit of Internal Medicine of San Giovanni in Fiore Hospital because of an increase in liver transaminases. Clinical evaluation showed the persistence of fever (38.8 degrees Celsius), with an increase in CPK, and liver enzymes. Pharmacological evaluation indicated a probable relationship between risperidone and NMS and led to a diagnosis of neuroleptic malignant syndrome associated with risperidone in a woman with schizophrenia. About seven days later, we recorded a complete resolution of her psychiatric symptoms. Discussion: We postulate a possible interaction between risperidone and neuroleptic malignant syndrome and we suggest to use risperidone with caution in both young and middle aged people.
Keywords: Risperidone, neuroleptic malignant syndrome, schizophrenic woman
Current Drug Safety
Title: A Case of Neuroleptic Malignant Syndrome Induced by Risperidone in a Schizophrenic Woman
Volume: 4 Issue: 2
Author(s): Luca Gallelli, Vincenzo Spagnuolo, Caterina Palleria, Giovambattista De Sarro and Maria Ferraro
Affiliation:
Keywords: Risperidone, neuroleptic malignant syndrome, schizophrenic woman
Abstract: Objective: We report a case of neuroleptic malignant syndrome in a woman who assumed risperidone for schizoaffective disorders. Case Summary: A 45-year-old woman affected by schizoaffective disorders was admitted to Infectious Disease unit of Crotone Hospital because of a diagnosis of a fever of unknown origin. Clinical evaluation documented confusion and dysphoria, whereas chemical blood evaluation revealed acidosis and liver dysfunction. After few days she was transferred to the Operative Unit of Internal Medicine of San Giovanni in Fiore Hospital because of an increase in liver transaminases. Clinical evaluation showed the persistence of fever (38.8 degrees Celsius), with an increase in CPK, and liver enzymes. Pharmacological evaluation indicated a probable relationship between risperidone and NMS and led to a diagnosis of neuroleptic malignant syndrome associated with risperidone in a woman with schizophrenia. About seven days later, we recorded a complete resolution of her psychiatric symptoms. Discussion: We postulate a possible interaction between risperidone and neuroleptic malignant syndrome and we suggest to use risperidone with caution in both young and middle aged people.
Export Options
About this article
Cite this article as:
Gallelli Luca, Spagnuolo Vincenzo, Palleria Caterina, De Sarro Giovambattista and Ferraro Maria, A Case of Neuroleptic Malignant Syndrome Induced by Risperidone in a Schizophrenic Woman, Current Drug Safety 2009; 4 (2) . https://dx.doi.org/10.2174/157488609788173062
DOI https://dx.doi.org/10.2174/157488609788173062 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Comparison of Midwifery Consultation and Fluoxetine on IVF Outcomes in Depressed Infertile Women: A Clinical Trial Research Study
Current Women`s Health Reviews Instructions from the Vascular System - Directing Neural Stem Cell Fate in Health and Disease
Current Medicinal Chemistry Aspartame: Should Individuals with Type II Diabetes be Taking it?
Current Diabetes Reviews Sympathetic Nervous System Dysfunction in Multiple Sclerosis, Linking Neurodegeneration to a Reduced Response to Therapy
Current Pharmaceutical Design Nesfatin-1; Implication in Stress and Stress-associated Anxiety and Depression
Current Pharmaceutical Design A Proteomics Perspective: From Animal Welfare to Food Safety
Current Protein & Peptide Science Alzheimer's disease: Targeting the Cholinergic System
Current Neuropharmacology Indications, Implications and Applications of Renal Denervation. Have we Discovered Something new?
Current Hypertension Reviews Host Neuro- Immuno-Endocrine Responses In Periodontal Disease
Current Pharmaceutical Design Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?
Current Neuropharmacology Role of Cytokines in Regulating Feeding Behaviour
Current Drug Targets Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile
Current Cancer Drug Targets The Metabolic Syndrome and the Relevance of Nutrients for its Onset
Recent Patents on Biotechnology Benzodiazepines, Amphetamines, Testosterone, and Sildenafil as New Candidate Drugs for Sexual Interest, Desire and/or Arousal Disorder
Current Psychopharmacology Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
Current Pharmaceutical Design Heart Disease Induced by AAS Abuse, Using Experimental Mice/Rats Models and the Role of Exercise-Induced Cardiotoxicity
Mini-Reviews in Medicinal Chemistry Advancements in Non-steroidal Antiandrogens as Potential Therapeutic Agents for the Treatment of Prostate Cancer
Mini-Reviews in Medicinal Chemistry Epigenetics and Perinatal Depression
Current Psychiatry Reviews Exposure to Enriched Environment Restores the mRNA Expression of Mineralocorticoid and Glucocorticoid Receptors in the Hippocampus and Ameliorates Depressive-like Symptoms in Chronically Stressed Rats
Current Neurovascular Research